Molecular assessment of mycobacterial burden in the treatment of nontuberculous mycobacterial disease.

Huw C EllisMiriam F MoffattColin ChurchwardLeah CuthbertsonWilliam O C CooksonMichael R Loebinger

Published in: ERJ open research (2023)

The quantitative PCR assays developed in this study provide affordable, real-time and rapid measurement of NTM burden, with significant implications for prompt management decisions.

Keyphrases

mycobacterium tuberculosis
high throughput
risk factors
combination therapy
single cell